|
⚲
|
| Keyboard |
| Steven Gordon | |
|---|---|
| Firm | |
| Address | 430 E 29th St New York, NY 10016 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Equilibre Biopharmaceuticals Corp | 021-466233 | Executive Officer | 6.0 M of 6.0 M |
||
| Equilibre Biopharmaceuticals Corp | 021-430166 | Executive Officer | 15.9 M of 25.0 M |
||
| Graviton Bioscience Corp | 021-389955 | Executive Officer | 3.5 M of 30.0 M |
||
| Equilibre Biopharmaceuticals Corp | 021-380339 | Executive Officer | 25.8 M of 35.8 M |
||
| Refinery 29 Inc | 021-340271 | Executive Officer | 8.0 M of 20.0 M |
||
| Kadmon Holdings LLC | 021-222099 | Executive Officer | 5.7 M of 50.0 M |
||
| Kadmon Holdings LLC | 021-183475 | Executive Officer | 4.7 M of 50.0 M |
||
| Kadmon I LLC | 021-145358 | Executive Officer | 10.8 M of 50.0 M |
||
| Lily Pond Currency Fund Ltd | 021-129366 | Director | 8.7 M | ||
| Lily Pond Investors Ltd | 021-94374 | Director | 20.0 M | ||
| Lily Pond Currency Plus Fund Ltd | 021-133607 | Director | 66.7 M | ||